enGene Therapeutics Ownership & Insider Activity

enGene Therapeutics (ENGN) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 4.8% of shares outstanding. Institutional investors hold 0.1%. Over the past 90 days, insiders made 1 purchase worth $10K.

Shares Outstanding

67.016M

Shares Float

54.401M

Insider Shares Owned

3.213M

Insider % Owned

4.8%

Institutional Shares Held

63.008K

Institutional % Held

0.1%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

$10K total

Sales (90d)

Net Activity

Net Buying

Net Value (90d)

$10K

enGene Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Sep 22, 2026	William Grossman	INTERIM CHIEF MEDICAL OFFICER	BUY	5.102K	$1.97	$10K